| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2025 | Oct 6, 2025 | NeueHealth, Inc. | Director | Sell | 27.5 | -1,160,514 | -37.34% | ✗ | $5.6K |
| Dec 23, 2024 | Dec 23, 2024 | Marker Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +554,250 | 51.73% | ✗ | $1.8M |
| Apr 11, 2022 | Apr 13, 2022 | Trevi Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +2,631,578 | 33.78% | ✗ | $5M |
| Mar 16, 2021 | Mar 18, 2021 | Marker Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +5,714,285 | 114.29% | ✗ | $10M |
| Apr 3, 2020 | Apr 13, 2020 | Trevi Therapeutics, Inc. | 10% Owner | Sell | 52.5 | -564 | -0.01% | ✗ | $1.5K |
| Jul 22, 2019 | Jul 24, 2019 | Mirum Pharmaceuticals, Inc. | 10% Owner | Buy | 100.0 | +450,000 | 12.04% | ✗ | $6.8M |
| May 9, 2019 | May 13, 2019 | Trevi Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +2,500,000 | 128.96% | ✗ | $25M |